Clinical utility of miRNA-1, miRNA-29g and miRNA-133s plasma levels in prostate cancer patients with high-intensity training after androgen-deprivation therapy.
About the publication
Record:
GAŽOVÁ, Andrea - ADAMIČKOVÁ, Adriana - LACZO, Eugen - HAMAR, Dušan - POLAKOVIČOVÁ, Maja - JURÍKOVÁ, Miroslava - KYSELOVIČ, Ján. Clinical utility of miRNA-1, miRNA-29g and miRNA-133s plasma levels in prostate cancer patients with high-intensity training after androgen-deprivation therapy. In: Physiological Research. 2019. ISSN 0862-8408, Roč. 68, suppl. 2 (2019), p. s139-s147.
(2019: 1.655 - IF, 67 - H-index, 1.820 - IF 5y, 0.651 - SJR, Q2 - SJR Best Q, Q4 - JCR Best Q)
(2019: 1.655 - IF, 67 - H-index, 1.820 - IF 5y, 0.651 - SJR, Q2 - SJR Best Q, Q4 - JCR Best Q)
Year:
2019
Category:
ADC - Scientific papers in foreign journals
Authors:
GAŽOVÁ Andrea
30 %
ADAMIČKOVÁ Adriana
10 %
LACZO Eugen
10 %
HAMAR Dušan
10 %
POLAKOVIČOVÁ Maja
5 %
JURÍKOVÁ Miroslava
5 %
30 %
UVMP share:
30 %
Edition:
Physiological Research
Roč. 68, suppl. 2 (2019), p. s139-s147
Country of issue:
Czech Republic
ISSN:
0862-8408
Research area:
180 - Medical, pharmaceutical and non-medical health sciences
Scientometrics:
2019: 1.655 - IF, 67 - H-index, 1.820 - IF 5y, 0.651 - SJR, Q2 - SJR Best Q, Q4 - JCR Best Q
Language:
english
Citations:
2023-2023: [1] CECCHI, M. - NINOT, G. - REBILLARD, X. - THURET, R. - DROUPY, S. - AYUSO, D. - POINAS, G. Which non pharmacological interventions should be offered to patients treated with androgen deprivation therapy for prostate cancer? A systematic review. In Progres en Urologie, 2023-05-01, 33, 6, pp. 287-306. ISSN 11667087. Dostupné na: https://doi.org/10.1016/j.purol.2023.03.005.